This month we would like to know...

How would you anticipate the passage of healthcare reform legislation will impact the activities/functions/role of the P&T Committee:

Vote in our survey, and see what other P&T committee members have to say.

Meeting Coverage

ACEI and ARB use in pregnancy an increasing concern
Despite being known teratogenic agents contraindicated in pregnancy, angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs) are being increasingly prescribed to women with hypertension during their childbearing years. This is leading to increased exposure to ACEIs and ARBs at the time of conception and during early pregnancy, and to an increased risk of serious birth defects and other adverse pregnancy outcomes, according to results of a study presented at the American College of Cardiology’s 59th annual scientific session. More...

Genetic testing may provide more accurate warfarin dose, lower risk of bleeding and clots
Physicians who check the DNA of patients before initiating warfarin therapy are more likely to provide the correct dose, avoiding the possibility of readmittance to a hospital, according to a new study presented in March at the American College of Cardiology’s 59th annual scientific session. More...

Use of ticagrelor leads to lower mortality after CABG surgery
Patients with acute coronary syndrome (ACS) who undergo coronary artery bypass graft (CABG) surgery are less likely to develop fatal outcomes when given ticagrelor instead of clopidogrel as an antiplatelet medication, according to research presented at the American College of Cardiology’s 59th annual scientific session in March. More...